CN1130466C - cDNA reducing hybrid difference display method on cDMA library base - Google Patents
cDNA reducing hybrid difference display method on cDMA library base Download PDFInfo
- Publication number
- CN1130466C CN1130466C CN 01129429 CN01129429A CN1130466C CN 1130466 C CN1130466 C CN 1130466C CN 01129429 CN01129429 CN 01129429 CN 01129429 A CN01129429 A CN 01129429A CN 1130466 C CN1130466 C CN 1130466C
- Authority
- CN
- China
- Prior art keywords
- cdna
- dna
- differential
- difference
- subtractive hybridization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002299 complementary DNA Substances 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims abstract description 55
- 238000009396 hybridization Methods 0.000 claims abstract description 70
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 38
- 238000004458 analytical method Methods 0.000 claims abstract description 17
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 9
- 239000012634 fragment Substances 0.000 claims description 44
- 238000001514 detection method Methods 0.000 claims description 18
- 230000008901 benefit Effects 0.000 claims description 10
- 230000029087 digestion Effects 0.000 claims description 9
- 238000012163 sequencing technique Methods 0.000 claims description 8
- 108010042407 Endonucleases Proteins 0.000 claims description 6
- 238000001976 enzyme digestion Methods 0.000 claims description 5
- 102000004533 Endonucleases Human genes 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 108091093088 Amplicon Proteins 0.000 abstract description 21
- 108090000623 proteins and genes Proteins 0.000 abstract description 16
- 238000005516 engineering process Methods 0.000 abstract description 9
- 230000002457 bidirectional effect Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 238000010367 cloning Methods 0.000 abstract description 3
- 238000012215 gene cloning Methods 0.000 abstract description 2
- 238000002372 labelling Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 69
- 239000000047 product Substances 0.000 description 45
- 238000012408 PCR amplification Methods 0.000 description 27
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 15
- 235000010081 allicin Nutrition 0.000 description 15
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 238000000636 Northern blotting Methods 0.000 description 11
- 108010006785 Taq Polymerase Proteins 0.000 description 11
- 230000014509 gene expression Effects 0.000 description 11
- 230000003321 amplification Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 5
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 5
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 102100031780 Endonuclease Human genes 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 230000003828 downregulation Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 240000002234 Allium sativum Species 0.000 description 3
- 102000003908 Cathepsin D Human genes 0.000 description 3
- 108090000258 Cathepsin D Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102000000993 Interphotoreceptor matrix proteoglycan Human genes 0.000 description 3
- 108050007996 Interphotoreceptor matrix proteoglycan Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000004611 garlic Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000003827 upregulation Effects 0.000 description 3
- 102100023973 Bax inhibitor 1 Human genes 0.000 description 2
- 102100035139 Folate receptor alpha Human genes 0.000 description 2
- 101150043805 HADHA gene Proteins 0.000 description 2
- 101001122938 Homo sapiens Lysosomal protective protein Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 102100028524 Lysosomal protective protein Human genes 0.000 description 2
- 102000005881 S100 Calcium Binding Protein A6 Human genes 0.000 description 2
- 108010005260 S100 Calcium Binding Protein A6 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 101710113263 Bax inhibitor 1 Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical group [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010059081 Cathepsin A Proteins 0.000 description 1
- 102000005572 Cathepsin A Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108700017309 Drosophila scrt Proteins 0.000 description 1
- 102000010451 Folate receptor alpha Human genes 0.000 description 1
- 108050001931 Folate receptor alpha Proteins 0.000 description 1
- 102000034353 G alpha subunit Human genes 0.000 description 1
- 108091006099 G alpha subunit Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 101000903937 Homo sapiens Bax inhibitor 1 Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000011496 cAMP-mediated signaling Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000011509 clonal analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 108700025184 hepatitis B virus X Proteins 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
cDNA文库基础上cDNA消减杂交差异显示方法,是一种分子生物学基因克隆分析方法,属于分子生物学领域。它是利用cDNA文库载体的限制性内切酶酶切位点,酶切选代表制备两文库扩增子,进行两文库扩增子间的双向一轮消减杂交,在各自一轮差异产物间进行双向二轮消减杂交,两轮差异产物标记同位素后引入mRNA差异显示技术进行差异分析。该方法为cDNA文库提供了新的应用前景,为克隆低丰度弱差异的基因提供了有效的手段。
The cDNA subtractive hybridization differential display method based on the cDNA library is a molecular biology gene cloning analysis method and belongs to the field of molecular biology. It utilizes the restriction endonuclease cutting site of the cDNA library carrier, and the restriction endonuclease selection represents the preparation of the amplicons of the two libraries, and performs a bidirectional round of subtractive hybridization between the amplicons of the two libraries. Bidirectional two-round subtractive hybridization, after two rounds of differential product labeling with isotopes, mRNA differential display technology was introduced for differential analysis. This method provides a new application prospect for cDNA library, and provides an effective means for cloning low-abundance and weakly differential genes.
Description
cDNA文库基础上cDNA消减杂交差异显示方法(SHDD)是一种分子生物学基因克隆分析方法,属于分子生物学领域。The cDNA subtractive hybridization difference display method (SHDD) based on cDNA library is a molecular biology gene clone analysis method, which belongs to the field of molecular biology.
现有的基因克隆方法很多,据文献报道最通用的方法主要有两种,一种是cDNA代表性差异分析方法(cDNA RDA),一种是mRNA差异显示方法(mRNA DD)。There are many existing gene cloning methods, and according to literature reports, there are two most common methods, one is cDNA representative difference analysis method (cDNA RDA), and the other is mRNA differential display method (mRNA DD).
(一)cDNA代表性差异分析方法(cDNA RDA)(1) cDNA Representative Difference Analysis (cDNA RDA)
基因组消减杂交方法是cDNA RDA建立的工作基础,所谓基因组消减杂交就是为了从两种相关的DNA样本(检测DNA和驱动DNA)中分离出检测DNA所具有的特异性序列,一定量的检测DNA(TesterDNA)与过量的驱动DNA(Driver DNA)进行杂交,使检测DNA中与驱动DNA相同的大部分序列发生杂和性复性,而检测DNA中特有的DNA片段发生自身复性,从而被分离出来。cDNA RDA方法在经典基因组消减杂交方法基础上引入了PCR扩增为主的动力学富集过程,通过消减两样本间的等同信息、富集差异信息,以其较高的特异性特点在克隆、鉴定不同发育阶段、不同周期时相、药物、细胞因子或病原体诱导前后组织细胞差异表达的基因等研究领域已得到广泛的应用。但是该方法存在以下几点不足:(1)经典的cDNA RDA方法采用溴乙锭显带,通常需经过三轮消减杂交才可获得明显的差异条带,较高的消减杂交比例以及每轮杂交后的多轮PCR扩增导致驱动DNA、一轮差异产物(DP1)、二轮差异产物(DP2)的片段群分布趋势依次递减,在二轮和三轮消减杂交中就存在了驱动DNA与一轮和二轮差异产物片段群间的不均衡消减杂交问题。驱动DNA与一轮和二轮差异产物的重叠区,也即差异产物片段群的偏长区域遭受较高消减杂交比例的抽提而发生信息量丢失;差异产物片段群的偏短区域在驱动DNA中仅有很少的对应序列,遭受的抽提效果较弱从而作为假阳性信息出现。这一发现为利用经典的cDNA RDA方法获得的差异产物中存在的信息量偏低和假阳性问题提供了一种合理的解释。(2)采用经典的cDNA RDA方法只能检测两个配对样本DNA之间的差异,并且只能获得检测DNA中表达水平增高的mRNA差异信息,不能同时获得表达水平下调的信息。(二)mRNA差异显示方法(mRNA DD)The genomic subtractive hybridization method is the working basis of cDNA RDA. The so-called genomic subtractive hybridization is to separate the specific sequence of the detection DNA from two related DNA samples (detection DNA and driver DNA). A certain amount of detection DNA ( Tester DNA) hybridizes with excess driver DNA (Driver DNA), so that most of the sequences in the test DNA that are identical to the driver DNA undergo hybrid annealing, and the unique DNA fragments in the test DNA undergo self-annealing and are separated . The cDNA RDA method introduces a kinetic enrichment process based on PCR amplification on the basis of the classic genome subtractive hybridization method. Identification of genes differentially expressed in tissue cells before and after induction by different developmental stages, different cycle phases, drugs, cytokines, or pathogens has been widely used in research fields. However, this method has the following disadvantages: (1) The classic cDNA RDA method uses ethidium bromide to develop the bands, usually three rounds of subtractive hybridization are required to obtain obvious differential bands, the higher ratio of subtractive hybridization and each round of hybridization After multiple rounds of PCR amplification, the distribution trend of fragment groups of driver DNA, first-round differential product (DP1), and second-round differential product (DP2) decreased successively. The problem of disequilibrium subtractive hybridization between fragment populations of first- and second-round differential products. The overlapping region between the driver DNA and the first and second rounds of differential products, that is, the longer region of the differential product fragment group is extracted by a higher subtractive hybridization ratio and the amount of information is lost; the shorter region of the differential product fragment group is in the driver DNA There are only few corresponding sequences in , which suffer from weak extraction effect and appear as false positive information. This finding provides a reasonable explanation for the low information content and false positives in the differential products obtained by the classical cDNA RDA method. (2) The classic cDNA RDA method can only detect the difference between the DNA of two paired samples, and can only obtain the mRNA difference information of the increased expression level in the detected DNA, and cannot obtain the information of the down-regulated expression level at the same time. (2) mRNA differential display method (mRNA DD)
mRNA DD方法利用是随机引物和锚定引物对两种不同来源的mRNA信息群进行聚合酶链式反应扩增(PCR),扩增产物行变性聚丙烯酰胺凝胶电泳,对比挑选差异表达片段。采用mRNA DD方法可同时比较多个样本间基因表达的差异,并可同时检测表达“上调”及“下调”的基因;对目的序列的扩增依赖于随机引物与锚定引物的不同组合,而不是依赖于目的序列的丰度,而且同位素的应用也有利于筛查得到较低丰度差异表达的信息。自1992年建立mRNA DD方法建立以来,人们已利用该技术以及在此基础上进一步改良的方法获得了数目可观的肿瘤相关基因。经过数年的实践,人们也发现了这项技术的一些不足之处,主要包括:The mRNA DD method uses random primers and anchor primers to perform polymerase chain reaction amplification (PCR) on mRNA information groups from two different sources, and the amplified products are subjected to denaturing polyacrylamide gel electrophoresis to compare and select differentially expressed fragments. Using the mRNA DD method, the difference in gene expression between multiple samples can be compared at the same time, and the "up-regulated" and "down-regulated" genes can be detected at the same time; the amplification of the target sequence depends on different combinations of random primers and anchor primers, while It is not dependent on the abundance of the target sequence, and the application of isotope is also conducive to screening to obtain information of lower abundance differential expression. Since the establishment of the mRNA DD method in 1992, people have obtained a considerable number of tumor-related genes by using this technology and further improved methods on this basis. After several years of practice, people have also found some shortcomings of this technology, mainly including:
(1)假阳性率高:许多研究表明,mRNA差异显示技术所呈现的差异条带有70%以上并不能为Northern印迹杂交及反向Northern印迹杂交等方法所证实。分析原因,主要与以下因素有关:随机引物特异性低;mRNA样品易发生降解或存在DNA的污染;由于使用3′端锚定引物,通过该方法获得的大多数差异条带仅含有3′端非翻译区(3′-UTR)的一段短片段信息,而该区域序列相对保守,使得以3′端cDNA片段作探针进行Northern印迹杂交可能出现假阳性问题。(1) High false positive rate: Many studies have shown that more than 70% of the differential bands presented by mRNA differential display technology cannot be confirmed by methods such as Northern blot hybridization and reverse Northern blot hybridization. The reasons for the analysis are mainly related to the following factors: low specificity of random primers; mRNA samples are prone to degradation or DNA contamination; due to the use of 3′ end anchor primers, most of the differential bands obtained by this method only contain 3′ ends A short piece of information in the untranslated region (3'-UTR), and the sequence of this region is relatively conserved, which may cause false positives in Northern blot hybridization using the 3'-terminal cDNA fragment as a probe.
(2)对低丰度mRNA检出率低:真核细胞中,相当数量的mRNA属于低丰度信息,86%的基因仅占mRNA总量的25%[10],由于PCR的竞争性扩增,mRNA DD技术对克隆高丰度mRNA有明显的倾向性[11]。(2) Low detection rate for low-abundance mRNA: in eukaryotic cells, a considerable amount of mRNA belongs to low-abundance information, and 86% of genes account for only 25% of the total amount of mRNA [10] . Due to the competitive amplification of PCR mRNA DD technology has a clear tendency to clone high-abundance mRNA [11] .
(3)巨大的工作量问题:由于凝胶差异显示前该方法不对匹配样本中的等同信息进行消减,使得电泳结果显示的单一条带位置含有1-10种不同的cDNA序列,平均4种,进一步分离鉴定这些信息已成为mRNA DD最为耗时、耗力的步骤。而且由于不同的随机引物结合到同一目的序列的特定区域或是不同的锚定引物与同一随机引物组合扩增同一目的序列导致重复差异片段问题,进一步增加了工作量。(3) Huge workload problem: Since the method does not subtract the equivalent information in the matched samples before the gel difference is displayed, the single band position displayed by the electrophoresis result contains 1-10 different cDNA sequences, with an average of 4 kinds. Further isolation and identification of these information has become the most time-consuming and labor-intensive step of mRNA DD. Moreover, because different random primers bind to specific regions of the same target sequence or different anchor primers are combined with the same random primer to amplify the same target sequence, the problem of repeated differential fragments further increases the workload.
本发明的目的在于为充分利用cDNA文库所包含的丰富的cDNA信息,进行文库间的基因表达差异分析;为克隆低丰度和弱差异的表达基因信息,避免经典cDNA RDA方法不均衡消减杂交导致的信息量低和假阳性问题,以及mRNA DD方法存在的假阳性和巨大工作量问题,发明一种cDNA文库基础上cDNA消减杂交差异显示方法。The purpose of the present invention is to make full use of the abundant cDNA information contained in the cDNA library to analyze the gene expression difference between the libraries; to clone the expressed gene information with low abundance and weak difference, and to avoid the unbalanced subtractive hybridization caused by the classical cDNA RDA method. In order to solve the problems of low information content and false positives in the mRNA DD method, and the problems of false positives and huge workload in the mRNA DD method, a cDNA subtractive hybridization differential display method based on cDNA library was invented.
本发明的目的是通过以下技术方案实现的。它利用cDNA文库所包含的丰富的cDNA信息,以大蒜的有效提取物大蒜素(Allitridi)处理和未处理的人胃癌细胞系BGC823细胞cDNA文库(Alli823cDNA文库和BGC823 cDNA文库)为样本,进行大蒜素处理前后人胃癌细胞系差异表达基因的克隆分析。结合文库载体自身所具有的酶切位点,选用限制性内切酶Xho I和BamH I双酶切选代表并行PCR扩增以制备两文库的扩增子,以两文库扩增子分别作为检测DNA和驱动DNA进行双向一轮消减杂交并降低杂交比例,而后以各自一轮消减杂交差异产物分别作为检测DNA和驱动DNA进行双向二轮消减杂交,两轮差异产物分别标记同位素α-35S dATP后引入mRNA DD差异显示技术,并结合反向Northern印迹杂交进行差异片段筛选。这种方法是在两个cDNA文库间开展两轮双向消减杂交基础上引入差异显示技术,故命名为cDNA文库基础上cDNA消减杂交差异显示方法(Subtractive Hybridization Difference Display,SHDD)。The purpose of the present invention is achieved through the following technical solutions. It utilizes the rich cDNA information contained in the cDNA library, and takes the effective extract of garlic (Allitridi) treated and untreated human gastric cancer cell line BGC823 cell cDNA library (Alli823cDNA library and BGC823 cDNA library) as samples to carry out allicin Clonal analysis of differentially expressed genes in human gastric cancer cell lines before and after treatment. Combined with the enzyme cutting sites of the library vector itself, the restriction endonucleases Xho I and BamH I were selected for double digestion to represent parallel PCR amplification to prepare the amplicons of the two libraries, and the amplicons of the two libraries were used as the detection DNA and driver DNA were subjected to bidirectional one-round subtractive hybridization and the hybridization ratio was reduced, and then the difference products of each round of subtractive hybridization were used as detection DNA and driver DNA for two-way two-way subtractive hybridization, and the difference products of the two rounds were respectively labeled with isotope α- 35 S dATP Later, mRNA DD differential display technology was introduced, combined with reverse Northern blot hybridization for differential fragment screening. This method introduces differential display technology based on two rounds of two-way subtractive hybridization between two cDNA libraries, so it is named as Subtractive Hybridization Difference Display (SHDD) based on cDNA library.
具体实施步骤:Specific implementation steps:
1.两个cDNA文库噬菌体DNA的制备:从大蒜素处理BGC823(简称Alli823)和BGC823亲本细胞cDNA文库中分别取1×106克隆铺盘,提取两cDNA文库噬菌体DNA,各约40μg;1. Preparation of phage DNA from two cDNA libraries: take 1×10 6 clones from allicin-treated BGC823 (Alli823 for short) and BGC823 parental cell cDNA libraries, respectively, and extract phage DNA from the two cDNA libraries, about 40 μg each;
2.两个cDNA文库噬菌体DNA扩增子(Amplicon,简称Amp)的制备:利用Xho I(10U/μl,Promega)对Alli823和BGC823文库DNA进行酶切,酶切体系70μl:文库DNA 50μl(40μg),10×缓冲液D(Buffer D)7μl,Xho I 6μl,去离子水7μl;37℃4小时酶切反应。酶切产物经酚-氯仿-异戊醇抽提后,连接Xho I 15,13接头(10μM),连接反应的体积为120μl(模板与接头比例=1∶10-30):模板DNA 60μl(40μg),Xho I 15接头(10μM)15μl,Xho I 13接头(10μM)15μl,10×T4连接酶Buffer 12μl,补去离子水至120μl;连接反应体系放置于50℃的温水烧杯中,1小时内从50℃逐步降至10℃,加T4连接酶(Biolab)400U,置16℃恒温水浴中20小时。连接后产物经BamHI(10U/μl,Promega)消化,酚-氯仿-异戊醇抽提后,再经QIAquick柱(QIAGEN)纯化,纯化后产物连接1RBam-12,24接头,连接反应体积、模板与接头比例及连接反应步骤同前。以连接产物为模板分别进行PCR扩增,反应体积为100μl(连接后产物1.5μl,2.5mM脱氧核糖核甘酸(dNTP)2μl,Taq DNA聚合酶(Taq DNA polymerase)10×buffer 10μl,50mM MgCl2 4μl,去离子水71.5μl),PCR反应程序为72℃3分钟→分别加入Taq DNA聚合酶(Promega,5U/μl)1μl→72℃5分钟→分别加入1RBam24引物(10μM)10μl→(95℃1分钟+72℃3分钟)×25个循环→72℃10分钟,扩增产物即为由两文库DNA制备的各自的扩增子(Alli823 Amp,BGC823 Amp),各需制备20μg;(SHDD方法扩增子制备原理图见附图1A)3.以两文库扩增子分别制备检测DNA(Tester DNA)和驱动DNA(Driver DNA):两文库扩增子(各约20μg)分别经BamH I酶切去除接头并经QIAquick柱纯化,纯化后产物既为由两文库DNA制备的各自的驱动DNA;纯化后产物分别取1/10(各约2μg)连接第二套接头(2JBam12,24),连接反应步骤同前,连接后产物既为两文库DNA各自的检测DNA;(步骤3-6的简要流程图见附图1B)4.检测DNA与驱动DNA的双向均衡一轮消减杂交:将1μg的检测DNA与20μg的驱动DNA混合(Tester∶Driver=1∶20),冷无水乙醇-20℃沉淀过夜,离心洗盐后溶于4μ13×EE Buffer,加入30μl高压灭菌石蜡油覆盖液面,95℃变性10分钟,再加入5M NaCl 1μl,于恒温箱内67℃,杂交20小时。检测DNA与驱动DNA第一轮杂交后的扩增,扩增反应体积100μl(杂交后产物0.8μl,2.5mM dNTP 2μl,10×Taq DNA Polymerase Buffer 10μl,50mM MgCl2 4μl),PCR反应程序为72℃3分钟→分别加入Taq DNA Polymerase 1μl→72℃5分钟→分别加入2JBam24引物(10μM)10μl→(95℃1分钟+70℃3分钟)×15个循环→72℃ 10分钟;PCR产物乙醇沉淀并洗盐后溶于30μl 1×TE中。应用绿豆芽核酸酶(MBN)消化单链DNA,上述PCR产物中加2μl(Biolab,10U/μl)MBN,10×NE Buffer 4μl,10×ZnSO4 Buffer 4μl;30℃消化35分钟。消化后产物经酚-氯仿-异戊醇抽提,乙醇沉淀并洗盐后,溶于10μl去离子水中。消化单链DNA后的PCR扩增反应体积80μl:消化单链DNA并灭活MBN后模板2.5μl,dNTP(2.5M)2μl,2JBam24引物(10μM)8μl,Taq DNAPolymerase 1μl,Taq DNA Polymerase Buffer(10×)8μl,补去离子水至80μl;反应条件:94℃3分钟→(94℃1分钟+70℃3分钟)×20个循环→72℃10分钟;扩增产物既为以两文库扩增子分别作为检测DNA获得的各自一轮消减杂交差异产物(DP1);5.检测DNA与驱动DNA的双向均衡二轮消减杂交:两文库一轮消减杂交差异产物(DP1)经BamH I酶切去除2JBaml2,24接头并经QIAquick柱纯化,纯化后产物既为由两文库DP1制备的各自驱动DNA;纯化后产物分别取1/10(各约2μg)连接3Nbaml2,24接头,连接反应步骤同前,连接后产物既为由两文库DP1制备的各自的检测DNA。将0.1μg的检测DNA与20μg的驱动DNA混合(Tester:Driver=1∶200),后续杂交反应、MBN消化单链DNA及PCR扩增制备两文库DNA各自二轮杂交差异产物(DP2)步骤同一轮杂交;6.一轮与二轮差异产物(DP1和DP2)的同位素标记及凝胶差异显示:以PCR法标记一轮与二轮差异产物,PCR反应体积20μl(模板10ng,2J/3NBam24(10μM)1.4μl,50mM MgCl2 0.8μl,25μMdC(GT)TP 1.5μl,25μM dATP 1.2μl,Taq DNA Polymerase 0.4μl,TaqDNA Polymerase Buffer(10×)5μl,α-35S-dATP(10μM)1.2μl,补去离子水至20μl);PCR反应条件:94℃3分钟→(94℃2分钟,70℃10分钟)×2个循环。测序胶差异显示:同位素标记后PCR产物3μl加3μl终止反应液,80℃变性2分钟后上样行凝胶电泳,电泳结束后胶不固定,直接粘到Whatman 3M滤纸上,上覆保鲜膜,80℃真空干燥3小时抽干,去保鲜膜,三点打孔定位,压X光片。切胶:三点定位切取差异条带,0.1×TE 50μl浸泡过夜。取适量上清做模板进行PCR再扩增,反应体系50μl:切胶浸泡液3μl,2J/3NBam24(10μM)3μl,50mM MgCl2 1.5μl,2.5mM dNTP 1μl,Taq DNA Polymerase0.4μl,Taq DNA Polymerase Buffer(10×)5μl,补去离子水至50μl;反应条件:94℃ 3分钟→(94℃1分钟,70℃ 3分钟)×30个循环→72℃ 10分钟,扩增产物既为应用SHDD方法获得的一轮与二轮差异片段;(测序胶差异显示及切胶回收片段再扩增结果见附图2A,2B)7.应用反向Northern印迹杂交对SHDD方法获得的一轮与二轮差异片段进行鉴定:分别取100ng差异片段PCR再扩增产物行1%琼脂糖凝胶电泳,应用盐桥转移法将片段DNA印迹转移至杂交膜;以构建Alli823 cDNA文库和BGC823 cDNA文库使用的双链cDNA做模板(各取100ng),以随机引物法分别行α-32P-dCTP标记;预杂交、杂交步骤同常规Northern印迹杂交;(反向Northern印迹杂交结果见附图3)8.反向Northern印迹杂交分析证实应用SHDD方法克隆得到10个经大蒜素诱导高表达的cDNA片段,其中7个已经测序证实分别来源于乙肝病毒X蛋白的抑制因子(XIP),叶酸受体α(FRα),钙结合蛋白(Calcyclin),神经胶质细胞来源的踝蛋白(GDN),组织蛋白酶D(Cathepsin D),β-半乳糖甘酶保护蛋白(PPGB),HADHA基因;获得6个大蒜素诱导低表达的cDNA片段,其中3个经测序证实来源于激活型G蛋白α亚单位(Gpalpl),睾丸增强基因转录本/Bax抑制因子1(TEGT/BI-1),人类interphotoreceptor基质蛋白多糖(IMPG2)基因;并同时获得经大蒜素诱导表达上调和下调的两个未知cDNA片段。本研究结果为阐明大蒜抗病毒、对抗多种人体肿瘤、神经系统退行性病变和心脑血管系统疾病的作用机制提供了有力的实验依据。获得了两条未知cDNA片段为进一步揭示大蒜有效成分预防疾病的生物学作用及分子机制奠定了基础。(测序及数据库同源性比较结果见表1)2. Preparation of two cDNA library phage DNA amplicons (Amplicon, referred to as Amp): Use Xho I (10U/μl, Promega) to digest Alli823 and BGC823 library DNA, enzyme digestion system 70μl: library DNA 50μl (40μg ), 7 μl of 10× buffer D (Buffer D), 6 μl of Xho I, 7 μl of deionized water; enzyme digestion reaction at 37°C for 4 hours. After the digested product was extracted with phenol-chloroform-isoamyl alcohol, it was connected to the Xho I 15, 13 adapter (10 μM), and the volume of the ligation reaction was 120 μl (ratio of template to adapter = 1:10-30): template DNA 60 μl (40 μg ), Xho I 15 Adapter (10μM) 15μl, Xho I 13 Adapter (10μM) 15μl, 10×T4 Ligase Buffer 12μl, add deionized water to 120μl; ligation reaction system placed in a warm water beaker at 50°C, within 1 hour Decrease gradually from 50°C to 10°C, add 400 U of T4 ligase (Biolab), and place in a constant temperature water bath at 16°C for 20 hours. After ligation, the product was digested with BamHI (10U/μl, Promega), extracted with phenol-chloroform-isoamyl alcohol, and then purified by QIAquick column (QIAGEN). The ratio of linker and ligation reaction steps are the same as before. Carry out PCR amplification using the ligated product as a template, and the reaction volume is 100 μl (1.5 μl of the ligated product, 2 μl of 2.5 mM deoxyribonucleic acid (dNTP) , 10 μl of Taq DNA polymerase (Taq DNA polymerase) 10× buffer, 50 mM MgCl 2 4 μl, deionized water 71.5 μl), the PCR reaction program is 72 ° C for 3 minutes → add Taq DNA polymerase (Promega, 5U/μl) 1 μl → 72 ° C for 5 minutes → add 1RBam24 primer (10 μM) 10 μl → (95 °
表1.利用SHDD方法获得的差异表达cDNA片段Table 1. Differentially expressed cDNA fragments obtained by using the SHDD method
大蒜素诱导表达片段序号 cDNA 生物学功能Biological function
上调 下调SH 2-3 Cathepsin D 溶酶体的标志性蛋白酶 +++++Up-regulation Down-regulation of SH 2-3 Cathepsin D Lysosomal marker protease +++++
蛋白降解、活化与抗原加工SH 4-1 未知基因序列 与人类14号染色体仅 +++ ,
19个碱基同源SH 6-1 GDN 凝血酶抑制剂 +
神经轴突延伸因子SH 7-1 PPGB β-半乳糖甘酶保护蛋白 ++SH 8-2 HADHA 脂肪酸β-氧化 +++SH 9-1 XIP 抑制HBx转录激活活性 ++++Nervichalot extension factor SH 7-1 PPGB β-galactose glycase protection protein ++ SH 8-2 Hadha fatty acid β-oxidation +++ SH 9-1 XIP inhibitory activity +++++
抑制HBV复制与增殖SH 13-2 Gpalpl 活化cAMP信号通路 +++Inhibition of HBV replication and proliferation SH 13-2 Gpalpl Activation of cAMP signaling pathway +++
促进细胞增殖SH 14-1 IMPG2 人类interphotoreceptor ++ Promoting cell proliferation SH 14-1 IMPG2 Human interphotoreceptor
基质蛋白多糖SH 17-1 TEGT/BI-1 抑制细胞凋亡 ++SH 18-3 未知基因序列 含S2H2锌指结构 ++
与果蝇Scrt基因部分同源DP 3-1 FRα 参与体内多种物质合成 ++++DP 3-2 Calcyclin 细胞周期相关蛋白 +++Partially homologous to the Drosophila Scrt gene DP 3-1 FRα FRα Participated in the synthesis of various substances in the body ++++ DP 3-2 Calcyclin Cell cycle-related proteins ++ +
参与钙离子信号传导通路SH 1 ND ++++SH 3 ND ++++SH 10 ND ++SH 11 ND +++SH 16 ND ++++SH 19 ND +++注:“+”代表基因表达水平上调或下调一倍;“ND”代表未测序。Participate in calcium ion signal
本发明与现有技术相比,它的优点在于以下几个方面:为便于叙述,将两文库各自的mRNA信息群都划分为三种类型:优势信息;等同信息;弱势信息。对Alli823 cDNA文库而言,大蒜素诱导上调的信息为优势信息,诱导下调的信息为弱势信息;对BGC823cDNA文库而言,大蒜素诱导上调的信息为弱势信息,诱导下调的信息为优势信息,而大蒜素未影响的信息为两文库DNA的等同信息。Compared with the prior art, the present invention has the following advantages: for the convenience of description, the respective mRNA information groups of the two libraries are divided into three types: superior information; equivalent information; weak information. For Alli823 cDNA library, allicin-induced up-regulation information is dominant information, and allicin-induced down-regulation information is weak information; for BGC823 cDNA library, allicin-induced up-regulation information is weak information, and allicin-induced down-regulation information is dominant information, while allicin-induced down-regulation information is dominant information. The information not affected by allicin is the equivalent information of the DNA of the two libraries.
文库基础上cDNA消减杂交差异显示方法(SHDD)在充分利用cDNA文库提供的丰富的cDNA信息基础上,进一步结合了cDNARDA和mRNA DD两者的优点,同时又扩大了各自的优势并尽量避免了各自明显的缺点。Library-based cDNA subtractive hybridization difference display method (SHDD) further combines the advantages of cDNA RDA and mRNA DD on the basis of making full use of the rich cDNA information provided by the cDNA library, and at the same time expands their respective advantages and avoids their respective advantages as much as possible. Obvious disadvantage.
1.利用cDNA文库提供的丰富的cDNA信息及文库载体提供的限制性内切酶酶切位点,将消减杂交差异显示方法建立在cDNA文库基础上,为已有的大量cDNA文库提供了新的应用前景。1. Using the rich cDNA information provided by the cDNA library and the restriction endonuclease sites provided by the library vector, the subtractive hybridization differential display method is established on the basis of the cDNA library, which provides a new method for a large number of existing cDNA libraries. Application prospects.
2.与cDNA RDA比较,SHDD存在以下优势:2. Compared with cDNA RDA, SHDD has the following advantages:
(1)cDNA RDA方法以识别4个碱基位点的限制性内切酶酶切选代表(平均1个切点/256个碱基对(bp)),双链cDNA(平均2千个碱基对(kb))平均可切出7-8条片段,差异片段普遍偏短,特异性较低,而且存在数条差异片段来源于同一目的序列的结果重复问题;而SHDD结合了两个cDNA文库载体自身所具有的酶切位点,利用Xho I和BamH I双酶切选代表(平均1个切点/2kb),这样在保证扩增子信息量的同时又可获得较长差异片段,有利于提高后续Northern印迹杂交、序列同源性比较以及文库筛选的特异性;(1) The cDNA RDA method is selected by restriction endonucleases that recognize 4 base sites (average 1 cut point/256 base pairs (bp)), double-stranded cDNA (average 2,000 bases) Base pair (kb)) can cut out an average of 7-8 fragments, the difference fragments are generally short, the specificity is low, and there is a problem of duplication of the results of several difference fragments originating from the same target sequence; and SHDD combines two cDNA The enzyme cutting sites of the library vector itself are selected by Xho I and BamH I double enzyme digestion (average 1 cutting point/2kb), so that longer differential fragments can be obtained while ensuring the amount of amplicon information. It is beneficial to improve the specificity of subsequent Northern blot hybridization, sequence homology comparison and library screening;
(2)cDNA RDA方法需进行三轮乃至四轮消减杂交才可获得明显的差异片段,较高的消减杂交比例以及每轮杂交后的多轮PCR扩增导致驱动DNA、一轮差异产物、二轮差异产物的片段群分布趋势依次递减,在二轮和三轮消减杂交中就存在了驱动DNA与一轮和二轮差异产物片段群间的不均衡消减杂交问题,驱动DNA与一轮和二轮差异产物的重叠区,也即差异产物片段群的偏长区域遭受较高消减杂交比例的抽提而发生信息量丢失,差异产物片段群的偏短区域在驱动DNA中仅有很少的对应序列,遭受的抽提效果较弱从而作为假阳性信息出现;而SHDD方法则是在两样本间开展了双向一轮消减杂交和各自一轮差异产物间的双向均衡二轮消减杂交,从而避免了不均衡消减所导致的信息量丢失与假阳性问题;(2) The cDNA RDA method requires three or even four rounds of subtractive hybridization to obtain significant differential fragments. The distribution trend of the fragment groups of the differential products in the rounds decreases successively. In the second and third rounds of subtractive hybridization, there exists the problem of unbalanced subtractive hybridization between the driver DNA and the fragment groups of the first and second rounds of differential products. The overlapping region of the differential product, that is, the long region of the differential product fragment group is extracted by a high subtractive hybridization ratio and the information is lost, and the short region of the differential product fragment group has only a small correspondence in the driver DNA. Sequences suffer from weak extraction effects and appear as false positive information; while the SHDD method carries out a two-way subtractive hybridization between two samples and a two-way balanced two-round subtractive hybridization between two samples, thus avoiding Information loss and false positive problems caused by unbalanced reduction;
(3)双向一轮消减杂交突出了两样本各自的信息差异,而均衡二轮消减杂交又进一步放大该信息差异,高分辨率同位素差异显示技术的引入又替代了cDNA RDA溴乙锭显带的方法,因而可以只采用两轮消减杂交并降低消减杂交比例,有利于差减得到较低丰度和较弱的差异信息;(3) One round of bidirectional subtractive hybridization highlights the difference in information between the two samples, while the second round of balanced subtractive hybridization further amplifies the difference in information, and the introduction of high-resolution isotope difference display technology replaces the cDNA RDA ethidium bromide band. Therefore, only two rounds of subtractive hybridization can be used and the ratio of subtractive hybridization can be reduced, which is beneficial to obtain lower abundance and weaker difference information by subtraction;
(4)文库载体自身序列酶切后出现分别约22kb、11kb、6kb和850bp的四条明显带型,前三条序列较大,不会与目的序列选出的代表发生竞争性PCR扩增但可以作为内切酶消化适度的指标,从而提高了两样本扩增子之间的可比性;(4) Four obvious band patterns of about 22kb, 11kb, 6kb and 850bp appeared after digestion of the sequence of the library vector itself. The first three sequences are relatively large and will not compete with the representative of the target sequence for PCR amplification, but they can be used as Moderate index of endonuclease digestion, thereby improving the comparability between the amplicons of the two samples;
(5)载体序列来源的850bp片段代表两文库扩增子最高拷贝数的等同信息,可作为消减杂交抽提效果的评估依据。(5) The 850bp fragment derived from the carrier sequence represents the equivalent information of the highest copy number of amplicons in the two libraries, which can be used as the basis for evaluating the extraction effect of subtractive hybridization.
3.与mRNA DD相比,SHDD也具有着明显优势:3. Compared with mRNA DD, SHDD also has obvious advantages:
(1)mRNA DD由于随机引物和锚定引物与目的序列的非特异性结合及其他原因使得假阳性结果占有较高的比例,而且由于不同的随机引物结合到同一目的序列的特定区域或是不同的锚定引物与同一随机引物组合扩增同一目的序列导致重复差异片段问题;而SHDD的差异显示采用了24个碱基长的高度特异性引物,有效地解决了上述问题并有利于低丰度信息的扩增;(1) mRNA DD has a high proportion of false positive results due to the non-specific binding of random primers and anchor primers to the target sequence and other reasons, and because different random primers bind to specific regions of the same target sequence or different The combination of anchor primers and the same random primers to amplify the same target sequence leads to the problem of repeating difference fragments; while the difference display of SHDD uses 24 bases long highly specific primers, which effectively solves the above problems and benefits low-abundance information the expansion of
(2)mRNA DD由于自身设计上存在的问题导致差异结果中同一条带的位置可能包含几种不同的信息,进一步分离鉴定这些信息已成为mRNA DD最为耗时、耗力的步骤;而SHDD方法通过双向均衡两轮消减杂交突出了两样本各自的优势信息、等同信息均衡减弱、弱势信息显著压制,这在提高差异分析结果特异性的同时允许将两样本总mRNA间的差异信息集中在一板测序胶上进行差异显示分析,从而极大地简化了mRNA DD多种随机引物与锚定引物组合、多次测序胶电泳分析及后续复杂的筛查工作;(2) Due to the problems in the design of mRNA DD, the position of the same band in the difference results may contain several different information, and further separation and identification of these information has become the most time-consuming and labor-intensive step of mRNA DD; while the SHDD method Two-way balanced two rounds of subtractive hybridization highlighted the respective superior information of the two samples, weakened equivalent information balance, and significantly suppressed weak information, which allowed the differential information between the total mRNA of the two samples to be concentrated on one plate while improving the specificity of the differential analysis results Differential display analysis is performed on the sequencing gel, which greatly simplifies the combination of multiple random primers and anchor primers for mRNA DD, multiple sequencing gel electrophoresis analysis and subsequent complex screening work;
(3)载体序列来源的850bp片段由于代表了两文库扩增子最高拷贝数的等同信息,经过两轮温和消减杂交抽提后仍可能存在于各自二轮差异产物中,这就为后续差异显示分析提供了天然内对照,提高了实验的可重复性。(3) Since the 850bp fragment derived from the vector sequence represents the equivalent information of the highest copy number of the amplicons of the two libraries, it may still exist in the two rounds of differential products after two rounds of mild subtractive hybridization extraction, which is the basis for subsequent differential display. The assay provides a natural endogenous control, improving experimental reproducibility.
SHDD方法建立在cDNA文库基础上,并进一步结合了cDNA RDA的特异性特点与mRNA DD在双向筛查差异片段和较高的同位素检测灵敏度方面的优势。在具体技术路线设计上,SHDD的特点就是在两cDNA文库样本间双向一轮与二轮均衡、温和消减杂交基础上引入了同位素mRNA DD差异显示技术,使得该方法在克隆低丰度及弱差异信息,提高差异分析结果的特异性减少假阳性,减少重复差异结果,提高差异分析的信息量同时又降低工作量等方面明显优于经典的mRNA DD和cDNA RDA方法,为克隆低丰度弱差异的基因提供了有效的手段;并同时为cDNA文库提供了新的应用前景。(见表2)The SHDD method is based on the cDNA library, and further combines the specific characteristics of cDNA RDA with the advantages of mRNA DD in two-way screening of differential fragments and high isotope detection sensitivity. In terms of specific technical route design, SHDD is characterized by the introduction of isotopic mRNA DD differential display technology on the basis of bidirectional one-round and two-round equalization and mild subtractive hybridization between two cDNA library samples, making this method more effective in cloning low-abundance and weakly differential Information, improve the specificity of differential analysis results, reduce false positives, reduce repeated differential results, increase the amount of information in differential analysis while reducing the workload, etc. It is obviously superior to the classic mRNA DD and cDNA RDA methods, and is suitable for cloning low-abundance and weak differences The gene provides an effective means; and at the same time provides a new application prospect for the cDNA library. (See Table 2)
表2.SHDD与cDNA RDA,mRNA DD方法优缺点对比Table 2. Comparison of advantages and disadvantages of SHDD and cDNA RDA, mRNA DD methods
特异性 差异片段数量 工作量cDNA RDA +++ ++ ++mRNA DD + ++++ +++++SHDD +++ ++++ ++Specific difference fragments quantitative workload CDNA RDA +++ ++ ++ mRNA DD+++++ ++++ shdd +++++ ++ ++
下面结合附图和实施例对本发明做进一步细述。The present invention will be described in further detail below in conjunction with the accompanying drawings and embodiments.
附图1A为cDNA文库基础上cDNA消减杂交差异显示方法(SHDD)扩增子的制备。其中:λZAP II为cDNA文库构建使用的噬菌体载体;黑框代表文库载体序列,白框代表插入序列;Bam/B代表限制性内切酶BamH I,Xho/X代表限制性内切酶Xho I;Xho I接头内包含BamH I切点GGATCC。Accompanying drawing 1A is the preparation of the cDNA subtractive hybridization differential display method (SHDD) amplicon based on the cDNA library. Among them: λZAP II is the phage vector used for cDNA library construction; the black box represents the sequence of the library vector, and the white box represents the insertion sequence; Bam/B represents the restriction enzyme BamH I, and Xho/X represents the restriction enzyme Xho I; The Xho I linker contains the BamH I cutting point GGATCC.
附图1B为cDNA文库基础上cDNA消减杂交差异显示方法(SHDD)的简要流程图。其中:Alli Amp为由Alli823文库DNA制备的扩增子,BGC Amp为由BGC823文库DNA制备的扩增子;T代表检测DNA(Tester DNA),D代表检测DNA(Driver DNA);Alli DP1代表以Alli823扩增子作为检测DNA获得的一轮消减杂交差异产物,BGC DP1代表以BGC823扩增子作为检测DNA获得的一轮消减杂交差异产物;1st SH代表一轮消减杂交,2nd SH代表二轮消减杂交。Accompanying drawing 1B is the brief flowchart of cDNA subtractive hybridization differential display method (SHDD) based on cDNA library. Among them: Alli Amp is the amplicon prepared from the Alli823 library DNA, BGC Amp is the amplicon prepared from the BGC823 library DNA; T represents the test DNA (Tester DNA), D represents the test DNA (Driver DNA); Alli DP1 represents the Alli823 amplicon is used as a round of subtractive hybridization difference product obtained by detecting DNA, BGC DP1 represents a round of subtractive hybridization difference product obtained by using BGC823 amplicon as detection DNA; 1st SH represents a round of subtractive hybridization, 2nd SH represents two rounds of subtraction hybridize.
附图2A为应用SHDD方法获得的一轮及二轮差异产物(DP1和DP2)经同位素α-35S-dATP标记后测序胶差异显示的结果。其中:AlliDP1代表以Alli823扩增子作为检测DNA获得的一轮消减杂交差异产物,BGC DP1代表以BGC823扩增子作为检测DNA获得的一轮消减杂交差异产物。Fig. 2A is the result of sequencing gel differential display of the first-round and second-round differential products (DP1 and DP2) obtained by applying the SHDD method after being labeled with isotope α- 35S -dATP. Among them: AlliDP1 represents the differential product of a round of subtractive hybridization obtained by using the Alli823 amplicon as the detection DNA, and BGC DP1 represents the differential product of a round of subtractive hybridization obtained by using the BGC823 amplicon as the detection DNA.
附图2B为应用SHDD方法获得的一轮及二轮差异片段。Figure 2B is the first round and second round of differential fragments obtained by applying the SHDD method.
附图3为应用SHDD方法获得的一轮及二轮差异片段的反向Northern印迹杂交结果。其中(A)A-K分别代表差异片段SH 1,2,3,21,4,5,6,22,9,8,7.除片段SH 21(D)外,其余片段经大蒜素(Allitridi)处理后表达水平均见上调.(B)A-L分别代表差异片段SH 13,8,14,15,23,16,24,17,18,20,19,25.其中片段SH13,14,15,16,17,18,19经大蒜素处理后表达水平下调.GAPDH被用作反向Northern印迹杂交对照(Con).探针(Probe)Alli823为由大蒜素处理后BGC823细胞mRNA逆转录置换合成的双链cDNA(ds-cDNA);探针(Probe)BGC823为由亲本BGC823细胞mRNA逆转录置换合成的双链cDNA(ds-cDNA)。Accompanying drawing 3 is the reverse Northern blot hybridization result of one round and two rounds of differential fragments obtained by applying the SHDD method. Wherein (A)A-K represent difference fragments
实现发明的最佳实施例:The best embodiment for realizing the invention:
1.选择两个可比性强的cDNA文库(如药物处理与未处理细胞cDNA文库或某一脏器肿瘤组织与正常组织细胞cDNA文库)作为基因表达差异分析对象:如研究中采用的大蒜素处理与未处理BGC823细胞cDNA文库;1. Select two comparable cDNA libraries (such as drug-treated and untreated cell cDNA libraries or a certain organ tumor tissue and normal tissue cell cDNA library) as the object of gene expression difference analysis: such as the allicin treatment used in the study and untreated BGC823 cell cDNA library;
2.选择单一限制性内切酶或两种内切酶联合应用对文库DNA进行酶切选代表,内切酶酶切应保证选出代表的信息量,并同时注意内切酶不应将载体(噬菌体)DNA切出小于800bp的短片段,尽量避免载体DNA与插入序列的后续PCR竞争性扩增;本研究采用BamH I和Xho I双酶切选代表,文库载体自身序列酶切后出现分别约22kb、11kb、6kb和850bp的四条明显带型,前三条序列较大,不会与目的序列选出的代表发生竞争性PCR扩增但可以作为内切酶消化适度的指标;2. Choose a single restriction endonuclease or a combination of two endonucleases to digest the library DNA to select representatives. Endonuclease digestion should ensure the amount of information of the selected representatives, and at the same time, it should be noted that the endonuclease should not convert the carrier (Bacteriophage) DNA cuts out short fragments less than 800bp, and try to avoid the subsequent PCR competitive amplification of the vector DNA and the insert sequence; in this study, BamH I and Xho I double-enzyme digestion was used to select representatives, and the sequence of the library vector itself appeared differently after digestion. Four obvious band patterns of about 22kb, 11kb, 6kb and 850bp, the first three sequences are relatively large, and will not compete with the selected representative of the target sequence for PCR amplification, but can be used as an indicator of moderate endonuclease digestion;
3.不同的cDNA文库样本,差异表达基因的种类、丰度以及表达水平差异的程度不同,因而需根据具体的情况选择一轮与二轮的消减杂交比例,以尽量克隆得到低丰度、弱差异表达的基因,增加差异分析结果的信息量;本研究采用一轮消减杂交比例检测DNA∶驱动DNA=1∶20,二轮消减杂交比例检测DNA∶驱动DNA=1∶200;3. Different cDNA library samples have different types, abundances and expression levels of differentially expressed genes. Therefore, it is necessary to select the ratio of the first round and the second round of subtractive hybridization according to the specific situation, so as to clone as much as possible low abundance, weak genes. Differentially expressed genes increase the amount of information in differential analysis results; this study used a subtractive hybridization ratio of detection DNA:driver DNA=1:20, and a second round of subtractive hybridization ratio detection DNA:driver DNA=1:200;
4.两样本各自一轮差异产物之间及各自二轮差异产物之间应具有较好的可比性,PCR扩增的程度以测序胶差异显示观察到较多清晰的差异条带为宜,扩增循环数过少差异信息不能获得足够程度的富集,扩增循环数过多则会导致低丰度差异信息的丢失;而且选择不同的限制性内切酶酶切选出的代表扩增趋势不一致,因而需调整PCR扩增循环数以获得最佳差异分析结果;本研究采用的PCR扩增循环数为20个循环;4. There should be good comparability between the difference products of the two samples in each round and between the difference products of the two rounds. The degree of PCR amplification should be based on the differential display of the sequencing gel to observe more clear difference bands. If the number of amplification cycles is too small, the differential information cannot be enriched to a sufficient degree, and if the number of amplification cycles is too high, the low-abundance differential information will be lost; Inconsistent, so the number of PCR amplification cycles needs to be adjusted to obtain the best differential analysis results; the number of PCR amplification cycles used in this study is 20 cycles;
5.两轮差异产物应在调整好产物片段群趋势可比性的基础上,应用1-2个循环的PCR扩增分别标记同位素α-35S dATP;模板DNA以10ng为宜,经过2个循环的PCR扩增可获得40ng的产物,据此计算α-35S dATP与其他四种dNTP的用量(摩尔数)比例,以α-35SdATP∶dNTP=1∶30为宜;适当降低无同位素标记的dATP的用量,以在确保扩增片段完整性的基础上增加α-35S dATP的掺入率。5. On the basis of adjusting the trend comparability of product fragment groups, two rounds of differential products should be labeled with isotope α- 35 S dATP by 1-2 cycles of PCR amplification; the template DNA is preferably 10ng, after 2 cycles 40ng of product can be obtained by PCR amplification of α- 35 S dATP and the other four dNTPs (moles) according to which the ratio of α- 35 SdATP: dNTP = 1: 30 is advisable; In order to increase the incorporation rate of α- 35 S dATP on the basis of ensuring the integrity of the amplified fragment.
Claims (1)
- A kind of cDNA reducing hybrid difference display method on cDMA library base (SHDD), be based upon on the basis, cDNA library, and further combine representative difference analysis method of existing method cDNA (cDNA RDA) and mRNA difference display method (mRNA DD) advantage separately, it is characterized in that the restriction enzyme digestion sites that it utilizes abundant cDNA information in cDNA library and carrier to have, discharge the insertion sequence fragment as representative with suitable endonuclease digestion, the variance analysis of carrying out on this basis; And carry out two-way one as detection DNA with driving DNA respectively with two paired DNA (or cDNA) sample and take turns subtractive hybridization, obtain one to take turns the hybridization difference product separately; One take turns the hybridization difference product and prepare respectively and detect DNA and drive DNA separately with two samples respectively, further carry out two-way two on this basis and take turns subtractive hybridization and obtain two to take turns the subtractive hybridization difference product separately; Carrying out sequencing gel difference behind the two-wheeled difference product label isotope shows.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01129429 CN1130466C (en) | 2001-06-19 | 2001-06-19 | cDNA reducing hybrid difference display method on cDMA library base |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01129429 CN1130466C (en) | 2001-06-19 | 2001-06-19 | cDNA reducing hybrid difference display method on cDMA library base |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1392267A CN1392267A (en) | 2003-01-22 |
CN1130466C true CN1130466C (en) | 2003-12-10 |
Family
ID=4669167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01129429 Expired - Fee Related CN1130466C (en) | 2001-06-19 | 2001-06-19 | cDNA reducing hybrid difference display method on cDMA library base |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1130466C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8206924B2 (en) * | 2006-09-11 | 2012-06-26 | Osaka University | Trace mRNA amplification method and use thereof |
CN101597630B (en) * | 2009-03-19 | 2011-12-21 | 浙江大学 | cDNA homogenizing subtractive hybridizing method of double-stranded specific DNA enzyme mediation |
-
2001
- 2001-06-19 CN CN 01129429 patent/CN1130466C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1392267A (en) | 2003-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102485979B (en) | FFPE sample nucleic acid library, its construction method and FFPE sample analysis method | |
US5674682A (en) | Nucleic acid primers for detecting micrometastasis of prostate cancer | |
EP3090068B1 (en) | Method and kit for non-invasively detecting egfr gene mutations | |
JP7033602B2 (en) | Barcoded DNA for long range sequencing | |
JP6968894B2 (en) | Multiple detection method for methylated DNA | |
CN107201408B (en) | A method for developing sisal SSR primers based on transcriptome sequencing | |
CN102732629B (en) | Method for concurrently determining gene expression level and polyadenylic acid tailing by using high-throughput sequencing | |
CN113005200B (en) | Primer composition for detecting sarcoma fusion gene mutation, kit and application | |
WO2013056651A1 (en) | Method and probe for gene variation detection based on non-diagnostic purpose of fluorescence quenching | |
CN111378720A (en) | Construction method and application of sequencing library of long-chain non-coding RNA | |
WO2014079002A1 (en) | Tracing method and detection kit for test sample in next-generation sequencing technique of dna | |
WO2018133547A1 (en) | METHOD FOR CONSTRUCTING LIBRARY FOR NON-INVASIVE PRENATAL FETAL β-THALASSEMIA GENE MUTATION DETECTION, DETECTION METHOD AND KIT | |
CN105567847A (en) | Method for detecting polymorphism rs9005 of human stomach cancer susceptibility gene IL-1RN through MspI | |
CN106048021B (en) | Primer combination and its application for detecting P53 gene mutation in trace tissue | |
CN1130466C (en) | cDNA reducing hybrid difference display method on cDMA library base | |
WO2019085320A1 (en) | Methods and kits for targeted enrichment of target dna with high gc content | |
JP2023519979A (en) | Methods for detecting structural rearrangements within the genome | |
CN110452958B (en) | Joint, primer and kit for methylation detection of micro-fragmented nucleic acid and application of joint and primer and kit | |
CN114075564B (en) | Malassezia detection composition, kit and detection method thereof | |
CN113999896B (en) | Universal hairpin primer and application thereof in detection of microRNA | |
CN113462685B (en) | Probe composition for preventing reverse transcription of fungus conserved region and application thereof | |
CN105543388B (en) | Medical jurisprudence quick detection kit based on 21 mitochondria SNP sites | |
CN114381496A (en) | In-situ hybridization probe and preparation method and application thereof | |
CN110616255B (en) | Primer group, kit and identification method for identifying dental pulp stem cells and gingival stem cells by RNA level | |
CN103074418B (en) | General detection probe chip method for detecting nucleic acid degradation group |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20031210 |